Machine signal
Active cluster sell — 3 distinct insiders, $5.3M, window ends Sep 14, 2026.
Figures computed from official regulatory filings — .
Analysttarget 20.2 USD (+103%) · consensus 4.64/5 · 10 buy · 1 hold · 0 sell
Ownershipinsiders 0.89% · institutions 105.27% · short 11.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Korro Bio, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
27 buys283 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| FORMELA JEAN FRANCOIStrack record | Sell | $450.3K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $118.2K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $93.2K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $24.5K | SEC |
| Dolan Oliver | Sell | $68.6 | SEC |
| Dolan Oliver | Sell | $81.6 | SEC |
| Dolan Oliver | Sell | $99.3K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $712 | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $3.5K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $330.2K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $68.4K | SEC |
| Lynx1 Capital Management LPtrack record | Buy | $59.5K | conv 19 | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $5.1K | SEC |
| Lynx1 Capital Management LPtrack record | Buy | $19.3K | conv 17 | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $24.8K | SEC |
| Aiyar Ram | Sell | $62.9K | SEC |
| Chappell Todd | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vincent Loic A | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cerio Jeffrey | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dolan Oliver | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $1.2M | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $11.4K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $206.9K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $118.7K | SEC |
| FORMELA JEAN FRANCOIStrack record | Sell | $101.9K | SEC |